The data displays the top 20 pharmaceutical corporations by revenue in the U.S. in 2016. Pharmaceutical corporation Pfizer generated some 23.4 billion USD in revenue within the U.S.
Gilead Sciences | 26 |
Pfizer | 23.4 |
Johnson & Johnson | 23.3 |
Merck & Co. | 22.1 |
Amgen | 21.1 |
Teva | 21 |
AbbVie | 20.6 |
Sanofi | 20.1 |
Roche | 19.5 |
Novartis | 19 |
Eli Lilly | 17 |
AstraZeneca | 15.8 |
Novo Nordisk | 14.7 |
GlaxoSmithKline | 13.2 |
Allergan | 12.5 |
Bristol-Myers Squibb | 12 |
Mylan | 9.6 |
Valeant | 8.9 |
Boehringer Ingelheim | 8.8 |
Biogen | 8.7 |